These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1556889)

  • 21. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
    Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
    Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of laryngeal manual therapy in four Dutch adults with persistent moderate-to-severe vocal hyperfunction: a pilot study.
    Van Lierde KM; De Ley S; Clement G; De Bodt M; Van Cauwenberge P
    J Voice; 2004 Dec; 18(4):467-74. PubMed ID: 15567048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic difficulties in spasmodic dysphonia--case report].
    Szkiełkowska A; Miaśkiewicz B; Baczyńska-Swierczyńska S; Szymańska E
    Pol Merkur Lekarski; 2006 May; 20(119):557-9. PubMed ID: 16875162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
    Ford CN; Bless DM; Lowery JD
    Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technique for injection of botulinum toxin through the flexible nasolaryngoscope.
    Rhew K; Fiedler DA; Ludlow CL
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):787-94. PubMed ID: 7991260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia.
    Chhetri DK; Mendelsohn AH; Blumin JH; Berke GS
    Laryngoscope; 2006 Apr; 116(4):635-42. PubMed ID: 16585872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indications for botulinum toxin in laryngectomy].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
    Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Spasmodic dysphonia. Investigation and therapeutic methods].
    Marion MH; Klap P; Perrin A; Elbaz E
    Rev Neurol (Paris); 1992; 148(3):180-3. PubMed ID: 1604131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
    Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
    Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin injection and airflow stability in spasmodic dysphonia.
    Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S
    Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections.
    Aronson AE; McCaffrey TV; Litchy WJ; Lipton RJ
    Laryngoscope; 1993 Jun; 103(6):683-92. PubMed ID: 8502104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with collagen injection of the vocal fold: a study of 155 patients.
    Kimura M; Nito T; Sakakibara K; Tayama N; Niimi S
    Auris Nasus Larynx; 2008 Mar; 35(1):67-75. PubMed ID: 17804185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The evaluation of voice and aerodynamic activity of larynx in patients with vocal cords atrophy].
    Kosztyła-Hojna B
    Pol Merkur Lekarski; 2005 Feb; 18(104):151-5. PubMed ID: 17877119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin therapy for abductor spasmodic dysphonia.
    Woodson G; Hochstetler H; Murry T
    J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia.
    Adler CH; Bansberg SF; Krein-Jones K; Hentz JG
    Mov Disord; 2004 Sep; 19(9):1075-9. PubMed ID: 15372600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.